Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
GENinCode Announces Major US Commercialisation Partnership with EVERSANA
GENinCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of […]
Heartseed Raises $37 Million in Series C Funding to Accelerate Development of iPSC-derived Stem Cell Therapy for Heart Failure
Heartseed, a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure (HF), today announced it […]
Medtech Accelerator Sofinnova MD Start III Launches a Call for Early Stage Medical Device Projects
Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and […]
New Roche Data for Evrysdi Show Improved Motor Function in Pre-symptomatic Babies after One Year
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new interim data from two studies of […]
New Data Shows AbbVie's VENCLYXTO/VENCLEXTA Fixed Duration Combination Demonstrates Sustained Progression-Free Survival in Chronic Lymphocytic Leukemia Patients after Three Years off Treatment
AbbVie (NYSE: ABBV) today announced results from a four-year follow-up analysis of the Phase 3 […]
NHS Ahead of Target in Recovery of Elective Care, and Mental Health Services Back to Pre-pandemic Levels
Operations and other routine care are ahead of ambitions set out in April with mental […]
Medtronic Announces FDA Approval of its Next Generation Recharge-Free Spinal Cord Stimulation Platform
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced it has received […]
Onxeo Receives Notice of Allowance for a New Patent Broadening the Protection of AsiDNA™ in combination with a PARP Inhibitor in the United States
Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), hereafter “Onxeo” or “the Company”, a clinical-stage biotechnology company specializing in […]
Hawthorne Effect Completes $20 Million Series A Round of Financing to Decentralize Clinical Trials
Hawthorne Effect™, a solution for decentralizing clinical trials, today announced the successful closing of a $20 […]
Medixine Raises €2.9M Funding to Help Healthcare Providers Offer Comprehensive Remote Care Services
The Finland-based telehealth provider Medixine has raised €2.9 million in funding led by a crowdfunding […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more